What happened with AIFU today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
AIFU connects individuals in China with life and health insurance supplied by partner insurers, mainly through affiliated sales agents who are not employees. These policies generate most of its revenue; property and casualty insurance and brokerage services for businesses contribute a smaller share. It has sold its former online distribution platform, Baowang, and its claims-adjusting business, leaving insurance distribution as its core operation.
Insurers pay AIFU commissions and fees generally tied to customers’ premiums. For long-term life and health policies, AIFU earns an initial commission and smaller commissions on later renewal premiums, provided customers keep paying and renewing. Its income therefore depends on new policy sales, continued renewals and the rates insurers pay.
The business also relies on retaining productive agents and maintaining important insurer relationships, including Sinatay, which supplies a significant share of revenue. Chinese rules require personnel doing insurance agency work to register with the regulator. Life-insurance pricing and distribution-expense controls also constrain the products insurers can offer and the commissions they can pay.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
AIFU depends on Chinese life-insurance demand, regulated commission rates and insurer relationships—watch Sinatay, which contributed 13.5% of its 2025 net revenues excluding estimated renewal commissions.
Huize competes with AIFU for Chinese consumers buying life and health insurance; both distribute insurers’ policies and receive commissions from those insurers rather than underwrite the coverage. Watch Huize’s life and annuity premiums for a read on demand in AIFU’s core market.
Waterdrop gives individuals a direct alternative to AIFU for buying health and life policies from multiple insurers; both earn insurer-paid commissions tied to premiums. Watch Waterdrop’s long-term health and life offering for how its competing product range develops.
Yuanbao competes with AIFU to distribute insurers’ health and life policies to Chinese consumers, but focuses much more heavily on medical and critical illness coverage. Its new-policy counts in those two categories offer a narrower view of health-insurance demand than AIFU’s broader life and health business, which earns commissions from insurers.
Zhibao competes with AIFU for insurer-paid distribution commissions in China, but puts insurance offers inside business partners’ customer platforms rather than relying mainly on agents as AIFU does. Its brokerage revenue shows how this alternative sales channel is developing.
Huize Holding Limited earningsHUIZ
Huize’s life and annuity premiums show demand for policies that overlap with AIFU’s core insurance-distribution business.
Watch Huize’s life and annuity premiums. Rising premiums would suggest firmer consumer demand in a market AIFU also serves; falling premiums would suggest demand may still constrain both distributors’ efforts to place policies and earn insurer-paid commissions.
Yuanbao Inc. earningsYB
Yuanbao’s new medical and critical illness policies show demand in health-insurance categories where it competes with AIFU.
Watch Yuanbao’s new-policy counts for medical and critical illness cover. Higher counts would point to stronger demand in categories AIFU also distributes, supporting the market for its insurer-paid commissions; lower counts would suggest weakness in this slice of health insurance, not necessarily across AIFU’s broader life-and-health business.
